16,982 research outputs found
Bayesian hierarchical clustering for studying cancer gene expression data with unknown statistics
Clustering analysis is an important tool in studying gene expression data. The Bayesian hierarchical clustering (BHC) algorithm can automatically infer the number of clusters and uses Bayesian model selection to improve clustering quality. In this paper, we present an extension of the BHC algorithm. Our Gaussian BHC (GBHC) algorithm represents data as a mixture of Gaussian distributions. It uses normal-gamma distribution as a conjugate prior on the mean and precision of each of the Gaussian components. We tested GBHC over 11 cancer and 3 synthetic datasets. The results on cancer datasets show that in sample clustering, GBHC on average produces a clustering partition that is more concordant with the ground truth than those obtained from other commonly used algorithms. Furthermore, GBHC frequently infers the number of clusters that is often close to the ground truth. In gene clustering, GBHC also produces a clustering partition that is more biologically plausible than several other state-of-the-art methods. This suggests GBHC as an alternative tool for studying gene expression data. The implementation of GBHC is available at https://sites.
google.com/site/gaussianbhc
Revisiting Precision and Recall Definition for Generative Model Evaluation
In this article we revisit the definition of Precision-Recall (PR) curves for
generative models proposed by Sajjadi et al. (arXiv:1806.00035). Rather than
providing a scalar for generative quality, PR curves distinguish mode-collapse
(poor recall) and bad quality (poor precision). We first generalize their
formulation to arbitrary measures, hence removing any restriction to finite
support. We also expose a bridge between PR curves and type I and type II error
rates of likelihood ratio classifiers on the task of discriminating between
samples of the two distributions. Building upon this new perspective, we
propose a novel algorithm to approximate precision-recall curves, that shares
some interesting methodological properties with the hypothesis testing
technique from Lopez-Paz et al (arXiv:1610.06545). We demonstrate the interest
of the proposed formulation over the original approach on controlled
multi-modal datasets.Comment: ICML 201
Recommended from our members
Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis.
Radiomics is an emerging technology for imaging biomarker discovery and disease-specific personalized treatment management. This paper aims to determine the benefit of using multi-modality radiomics data from PET and MR images in the characterization breast cancer phenotype and prognosis. Eighty-four features were extracted from PET and MR images of 113 breast cancer patients. Unsupervised clustering based on PET and MRI radiomic features created three subgroups. These derived subgroups were statistically significantly associated with tumor grade (p = 2.0 × 10-6), tumor overall stage (p = 0.037), breast cancer subtypes (p = 0.0085), and disease recurrence status (p = 0.0053). The PET-derived first-order statistics and gray level co-occurrence matrix (GLCM) textural features were discriminative of breast cancer tumor grade, which was confirmed by the results of L2-regularization logistic regression (with repeated nested cross-validation) with an estimated area under the receiver operating characteristic curve (AUC) of 0.76 (95% confidence interval (CI) = [0.62, 0.83]). The results of ElasticNet logistic regression indicated that PET and MR radiomics distinguished recurrence-free survival, with a mean AUC of 0.75 (95% CI = [0.62, 0.88]) and 0.68 (95% CI = [0.58, 0.81]) for 1 and 2 years, respectively. The MRI-derived GLCM inverse difference moment normalized (IDMN) and the PET-derived GLCM cluster prominence were among the key features in the predictive models for recurrence-free survival. In conclusion, radiomic features from PET and MR images could be helpful in deciphering breast cancer phenotypes and may have potential as imaging biomarkers for prediction of breast cancer recurrence-free survival
Modeling, Simulating, and Parameter Fitting of Biochemical Kinetic Experiments
In many chemical and biological applications, systems of differential
equations containing unknown parameters are used to explain empirical
observations and experimental data. The DEs are typically nonlinear and
difficult to analyze, requiring numerical methods to approximate the solutions.
Compounding this difficulty are the unknown parameters in the DE system, which
must be given specific numerical values in order for simulations to be run.
Estrogen receptor protein dimerization is used as an example to demonstrate
model construction, reduction, simulation, and parameter estimation.
Mathematical, computational, and statistical methods are applied to empirical
data to deduce kinetic parameter estimates and guide decisions regarding future
experiments and modeling. The process demonstrated serves as a pedagogical
example of quantitative methods being used to extract parameter values from
biochemical data models.Comment: 23 pages, 9 figures, to be published in SIAM Revie
Partition Decoupling for Multi-gene Analysis of Gene Expression Profiling Data
We present the extention and application of a new unsupervised statistical
learning technique--the Partition Decoupling Method--to gene expression data.
Because it has the ability to reveal non-linear and non-convex geometries
present in the data, the PDM is an improvement over typical gene expression
analysis algorithms, permitting a multi-gene analysis that can reveal
phenotypic differences even when the individual genes do not exhibit
differential expression. Here, we apply the PDM to publicly-available gene
expression data sets, and demonstrate that we are able to identify cell types
and treatments with higher accuracy than is obtained through other approaches.
By applying it in a pathway-by-pathway fashion, we demonstrate how the PDM may
be used to find sets of mechanistically-related genes that discriminate
phenotypes.Comment: Revise
The interplay of descriptor-based computational analysis with pharmacophore modeling builds the basis for a novel classification scheme for feruloyl esterases
One of the most intriguing groups of enzymes, the feruloyl esterases (FAEs), is ubiquitous in both simple and complex organisms. FAEs have gained importance in biofuel, medicine and food industries due to their capability of acting on a large range of substrates for cleaving ester bonds and synthesizing high-added value molecules through esterification and transesterification reactions. During the past two decades extensive studies have been carried out on the production and partial characterization of FAEs from fungi, while much less is known about FAEs of bacterial or plant origin. Initial classification studies on FAEs were restricted on sequence similarity and substrate specificity on just four model substrates and considered only a handful of FAEs belonging to the fungal kingdom. This study centers on the descriptor-based classification and structural analysis of experimentally verified and putative FAEs; nevertheless, the framework presented here is applicable to every poorly characterized enzyme family. 365 FAE-related sequences of fungal, bacterial and plantae origin were collected and they were clustered using Self Organizing Maps followed by k-means clustering into distinct groups based on amino acid composition and physico-chemical composition descriptors derived from the respective amino acid sequence. A Support Vector Machine model was subsequently constructed for the classification of new FAEs into the pre-assigned clusters. The model successfully recognized 98.2% of the training sequences and all the sequences of the blind test. The underlying functionality of the 12 proposed FAE families was validated against a combination of prediction tools and published experimental data. Another important aspect of the present work involves the development of pharmacophore models for the new FAE families, for which sufficient information on known substrates existed. Knowing the pharmacophoric features of a small molecule that are essential for binding to the members of a certain family opens a window of opportunities for tailored applications of FAEs
- …